Trial Profile
Hypotensive Efficacy of Topical Prophylaxis for Intraocular Pressure Spikes Following Intravitreal Injections of Anti-vascular Endothelial Growth Factor Agents
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Nov 2021
Price :
$35
*
At a glance
- Drugs Brimonidine (Primary)
- Indications Ocular hypertension
- Focus Therapeutic Use
- 07 May 2018 New trial record